Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007

    Basic Details
    Date Posted
    Friday, April 16, 2021
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    In this report we described baseline characteristics and the duration of follow-up time among new users of 20 new molecular entities (NMEs) approved in 2005, 22 NMEs approved in 2006, and 17 NMEs approved in 2007 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2005 - June 30, 2018; January 1, 2006 - June 30, 2018; January 1, 2007 - June 30, 2018
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)